Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
37.46
+0.60 (1.63%)
Feb 21, 2025, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 290 employees as of December 31, 2023. The number of employees increased by 80 or 38.10% compared to the previous year.
Employees
290
Change (1Y)
80
Growth (1Y)
38.10%
Revenue / Employee
$3,583
Profits / Employee
-$958,310
Market Cap
3.47B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CRNX News
- 2 days ago - Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences - GlobeNewsWire
- 12 days ago - Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness - Seeking Alpha
- 2 months ago - Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire